nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.167	0.463	CbGbCtD
Desvenlafaxine—CYP3A4—Progesterone—uterine cancer	0.11	0.306	CbGbCtD
Desvenlafaxine—CYP3A4—Etoposide—uterine cancer	0.0494	0.137	CbGbCtD
Desvenlafaxine—CYP3A4—Doxorubicin—uterine cancer	0.0337	0.0935	CbGbCtD
Desvenlafaxine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.0029	0.00454	CcSEcCtD
Desvenlafaxine—Vision blurred—Progesterone—uterine cancer	0.0029	0.00453	CcSEcCtD
Desvenlafaxine—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00289	0.00452	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00288	0.00451	CcSEcCtD
Desvenlafaxine—Tremor—Progesterone—uterine cancer	0.00288	0.0045	CcSEcCtD
Desvenlafaxine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00287	0.00449	CcSEcCtD
Desvenlafaxine—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.00442	CcSEcCtD
Desvenlafaxine—Angioedema—Progesterone—uterine cancer	0.00281	0.00439	CcSEcCtD
Desvenlafaxine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.0028	0.00438	CcSEcCtD
Desvenlafaxine—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00279	0.00435	CcSEcCtD
Desvenlafaxine—Vertigo—Progesterone—uterine cancer	0.00276	0.00432	CcSEcCtD
Desvenlafaxine—Syncope—Progesterone—uterine cancer	0.00276	0.00431	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00276	0.00431	CcSEcCtD
Desvenlafaxine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00427	CcSEcCtD
Desvenlafaxine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00426	CcSEcCtD
Desvenlafaxine—Palpitations—Progesterone—uterine cancer	0.00272	0.00425	CcSEcCtD
Desvenlafaxine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00271	0.00423	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Progesterone—uterine cancer	0.0027	0.00422	CcSEcCtD
Desvenlafaxine—Convulsion—Progesterone—uterine cancer	0.00266	0.00416	CcSEcCtD
Desvenlafaxine—Hypertension—Progesterone—uterine cancer	0.00265	0.00415	CcSEcCtD
Desvenlafaxine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00261	0.00408	CcSEcCtD
Desvenlafaxine—Anxiety—Progesterone—uterine cancer	0.00261	0.00408	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.0026	0.00406	CcSEcCtD
Desvenlafaxine—Dry mouth—Progesterone—uterine cancer	0.00256	0.004	CcSEcCtD
Desvenlafaxine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.00398	CcSEcCtD
Desvenlafaxine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00391	CcSEcCtD
Desvenlafaxine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00391	CcSEcCtD
Desvenlafaxine—Shock—Progesterone—uterine cancer	0.00247	0.00386	CcSEcCtD
Desvenlafaxine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00246	0.00385	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Progesterone—uterine cancer	0.00246	0.00385	CcSEcCtD
Desvenlafaxine—Tachycardia—Progesterone—uterine cancer	0.00245	0.00383	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00245	0.00383	CcSEcCtD
Desvenlafaxine—Skin disorder—Progesterone—uterine cancer	0.00244	0.00381	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Progesterone—uterine cancer	0.00243	0.00379	CcSEcCtD
Desvenlafaxine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00377	CcSEcCtD
Desvenlafaxine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00236	0.00369	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Dactinomycin—uterine cancer	0.00236	0.00369	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00368	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00235	0.00368	CcSEcCtD
Desvenlafaxine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00363	CcSEcCtD
Desvenlafaxine—Insomnia—Progesterone—uterine cancer	0.00227	0.00355	CcSEcCtD
Desvenlafaxine—Paraesthesia—Progesterone—uterine cancer	0.00225	0.00352	CcSEcCtD
Desvenlafaxine—Chills—Dactinomycin—uterine cancer	0.00224	0.0035	CcSEcCtD
Desvenlafaxine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.0035	CcSEcCtD
Desvenlafaxine—Bone disorder—Epirubicin—uterine cancer	0.00223	0.00349	CcSEcCtD
Desvenlafaxine—Somnolence—Progesterone—uterine cancer	0.00223	0.00349	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.00349	CcSEcCtD
Desvenlafaxine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00347	CcSEcCtD
Desvenlafaxine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00345	CcSEcCtD
Desvenlafaxine—Alopecia—Dactinomycin—uterine cancer	0.00221	0.00345	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.00344	CcSEcCtD
Desvenlafaxine—Decreased appetite—Progesterone—uterine cancer	0.00218	0.00341	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00217	0.00339	CcSEcCtD
Desvenlafaxine—Fatigue—Progesterone—uterine cancer	0.00216	0.00338	CcSEcCtD
Desvenlafaxine—Constipation—Progesterone—uterine cancer	0.00215	0.00335	CcSEcCtD
Desvenlafaxine—Bone disorder—Doxorubicin—uterine cancer	0.00207	0.00323	CcSEcCtD
Desvenlafaxine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00321	CcSEcCtD
Desvenlafaxine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00319	CcSEcCtD
Desvenlafaxine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00316	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00199	0.00312	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Epirubicin—uterine cancer	0.00199	0.00312	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Etoposide—uterine cancer	0.00198	0.0031	CcSEcCtD
Desvenlafaxine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00309	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Etoposide—uterine cancer	0.00197	0.00308	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00307	CcSEcCtD
Desvenlafaxine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00306	CcSEcCtD
Desvenlafaxine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00304	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Progesterone—uterine cancer	0.00185	0.00289	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Doxorubicin—uterine cancer	0.00184	0.00288	CcSEcCtD
Desvenlafaxine—Asthenia—Progesterone—uterine cancer	0.0018	0.00281	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Etoposide—uterine cancer	0.00178	0.00279	CcSEcCtD
Desvenlafaxine—Urethral disorder—Etoposide—uterine cancer	0.00177	0.00277	CcSEcCtD
Desvenlafaxine—Diarrhoea—Progesterone—uterine cancer	0.00172	0.00268	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Etoposide—uterine cancer	0.00171	0.00267	CcSEcCtD
Desvenlafaxine—Eye disorder—Etoposide—uterine cancer	0.00169	0.00264	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Etoposide—uterine cancer	0.00168	0.00262	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00262	CcSEcCtD
Desvenlafaxine—Dizziness—Progesterone—uterine cancer	0.00166	0.00259	CcSEcCtD
Desvenlafaxine—Angiopathy—Etoposide—uterine cancer	0.00164	0.00256	CcSEcCtD
Desvenlafaxine—Immune system disorder—Etoposide—uterine cancer	0.00163	0.00255	CcSEcCtD
Desvenlafaxine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00255	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Etoposide—uterine cancer	0.00163	0.00255	CcSEcCtD
Desvenlafaxine—Chills—Etoposide—uterine cancer	0.00162	0.00253	CcSEcCtD
Desvenlafaxine—Alopecia—Etoposide—uterine cancer	0.0016	0.0025	CcSEcCtD
Desvenlafaxine—Vomiting—Progesterone—uterine cancer	0.0016	0.00249	CcSEcCtD
Desvenlafaxine—Rash—Progesterone—uterine cancer	0.00158	0.00247	CcSEcCtD
Desvenlafaxine—Dermatitis—Progesterone—uterine cancer	0.00158	0.00247	CcSEcCtD
Desvenlafaxine—Headache—Progesterone—uterine cancer	0.00157	0.00246	CcSEcCtD
Desvenlafaxine—Hot flush—Epirubicin—uterine cancer	0.00156	0.00245	CcSEcCtD
Desvenlafaxine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00243	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Epirubicin—uterine cancer	0.00155	0.00243	CcSEcCtD
Desvenlafaxine—Decreased appetite—Dactinomycin—uterine cancer	0.00154	0.00241	CcSEcCtD
Desvenlafaxine—Dysgeusia—Etoposide—uterine cancer	0.00154	0.00241	CcSEcCtD
Desvenlafaxine—Fatigue—Dactinomycin—uterine cancer	0.00153	0.00239	CcSEcCtD
Desvenlafaxine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00235	CcSEcCtD
Desvenlafaxine—Nausea—Progesterone—uterine cancer	0.00149	0.00233	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Epirubicin—uterine cancer	0.00147	0.0023	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.00146	0.00229	CcSEcCtD
Desvenlafaxine—Hot flush—Doxorubicin—uterine cancer	0.00145	0.00226	CcSEcCtD
Desvenlafaxine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00226	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Doxorubicin—uterine cancer	0.00144	0.00224	CcSEcCtD
Desvenlafaxine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00224	CcSEcCtD
Desvenlafaxine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00224	CcSEcCtD
Desvenlafaxine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00223	CcSEcCtD
Desvenlafaxine—Vertigo—Etoposide—uterine cancer	0.00141	0.00221	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Etoposide—uterine cancer	0.00138	0.00216	CcSEcCtD
Desvenlafaxine—Convulsion—Etoposide—uterine cancer	0.00136	0.00213	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—uterine cancer	0.00136	0.00213	CcSEcCtD
Desvenlafaxine—Hypertension—Etoposide—uterine cancer	0.00136	0.00212	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.00135	0.00212	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Epirubicin—uterine cancer	0.00135	0.00211	CcSEcCtD
Desvenlafaxine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00211	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Epirubicin—uterine cancer	0.00134	0.00209	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00133	0.00208	CcSEcCtD
Desvenlafaxine—Breast disorder—Epirubicin—uterine cancer	0.00132	0.00207	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00132	0.00206	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Dactinomycin—uterine cancer	0.00131	0.00204	CcSEcCtD
Desvenlafaxine—Asthenia—Dactinomycin—uterine cancer	0.00127	0.00199	CcSEcCtD
Desvenlafaxine—Tachycardia—Etoposide—uterine cancer	0.00125	0.00196	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—uterine cancer	0.00125	0.00195	CcSEcCtD
Desvenlafaxine—Skin disorder—Etoposide—uterine cancer	0.00125	0.00195	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Etoposide—uterine cancer	0.00124	0.00194	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00124	0.00193	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—uterine cancer	0.00122	0.00191	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00122	0.00191	CcSEcCtD
Desvenlafaxine—Diarrhoea—Dactinomycin—uterine cancer	0.00121	0.0019	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00115	0.00181	CcSEcCtD
Desvenlafaxine—Paraesthesia—Etoposide—uterine cancer	0.00115	0.0018	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—uterine cancer	0.00115	0.0018	CcSEcCtD
Desvenlafaxine—Weight decreased—Epirubicin—uterine cancer	0.00114	0.00179	CcSEcCtD
Desvenlafaxine—Somnolence—Etoposide—uterine cancer	0.00114	0.00178	CcSEcCtD
Desvenlafaxine—Vomiting—Dactinomycin—uterine cancer	0.00113	0.00176	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00112	0.00175	CcSEcCtD
Desvenlafaxine—Rash—Dactinomycin—uterine cancer	0.00112	0.00175	CcSEcCtD
Desvenlafaxine—Decreased appetite—Etoposide—uterine cancer	0.00112	0.00174	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00111	0.00173	CcSEcCtD
Desvenlafaxine—Fatigue—Etoposide—uterine cancer	0.00111	0.00173	CcSEcCtD
Desvenlafaxine—Constipation—Etoposide—uterine cancer	0.0011	0.00172	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00107	0.00167	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—uterine cancer	0.00107	0.00167	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—uterine cancer	0.00106	0.00166	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—uterine cancer	0.00106	0.00166	CcSEcCtD
Desvenlafaxine—Nausea—Dactinomycin—uterine cancer	0.00105	0.00165	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00103	0.00162	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—uterine cancer	0.001	0.00156	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—uterine cancer	0.000995	0.00156	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—uterine cancer	0.000993	0.00155	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—uterine cancer	0.000984	0.00154	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—uterine cancer	0.000957	0.0015	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—uterine cancer	0.000946	0.00148	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Etoposide—uterine cancer	0.000945	0.00148	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—uterine cancer	0.000944	0.00148	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—uterine cancer	0.00094	0.00147	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000925	0.00145	CcSEcCtD
Desvenlafaxine—Asthenia—Etoposide—uterine cancer	0.000921	0.00144	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000921	0.00144	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—uterine cancer	0.000919	0.00144	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—uterine cancer	0.000918	0.00144	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—uterine cancer	0.000915	0.00143	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—uterine cancer	0.000913	0.00143	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—uterine cancer	0.000908	0.00142	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—uterine cancer	0.000895	0.0014	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—uterine cancer	0.000887	0.00139	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—uterine cancer	0.000886	0.00138	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—uterine cancer	0.000881	0.00138	CcSEcCtD
Desvenlafaxine—Diarrhoea—Etoposide—uterine cancer	0.000878	0.00137	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—uterine cancer	0.000876	0.00137	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—uterine cancer	0.000873	0.00137	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—uterine cancer	0.000869	0.00136	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—uterine cancer	0.000865	0.00135	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—uterine cancer	0.000863	0.00135	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—uterine cancer	0.000856	0.00134	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—uterine cancer	0.00085	0.00133	CcSEcCtD
Desvenlafaxine—Dizziness—Etoposide—uterine cancer	0.000849	0.00133	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—uterine cancer	0.000846	0.00132	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000844	0.00132	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—uterine cancer	0.000841	0.00131	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—uterine cancer	0.000831	0.0013	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—uterine cancer	0.000828	0.00129	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—uterine cancer	0.000821	0.00128	CcSEcCtD
Desvenlafaxine—Vomiting—Etoposide—uterine cancer	0.000816	0.00128	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—uterine cancer	0.000816	0.00128	CcSEcCtD
Desvenlafaxine—Rash—Etoposide—uterine cancer	0.000809	0.00127	CcSEcCtD
Desvenlafaxine—Dermatitis—Etoposide—uterine cancer	0.000808	0.00126	CcSEcCtD
Desvenlafaxine—Headache—Etoposide—uterine cancer	0.000804	0.00126	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—uterine cancer	0.0008	0.00125	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—uterine cancer	0.000799	0.00125	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—uterine cancer	0.000792	0.00124	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—uterine cancer	0.000792	0.00124	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—uterine cancer	0.00079	0.00124	CcSEcCtD
Desvenlafaxine—Palpitations—Epirubicin—uterine cancer	0.000779	0.00122	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—uterine cancer	0.000775	0.00121	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—uterine cancer	0.000769	0.0012	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—uterine cancer	0.000764	0.00119	CcSEcCtD
Desvenlafaxine—Nausea—Etoposide—uterine cancer	0.000762	0.00119	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—uterine cancer	0.000761	0.00119	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—uterine cancer	0.000748	0.00117	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000745	0.00117	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—uterine cancer	0.000734	0.00115	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—uterine cancer	0.000733	0.00115	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—uterine cancer	0.000731	0.00114	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—uterine cancer	0.000721	0.00113	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—uterine cancer	0.000717	0.00112	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—uterine cancer	0.000708	0.00111	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—uterine cancer	0.000707	0.0011	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—uterine cancer	0.000705	0.0011	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—uterine cancer	0.000704	0.0011	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—uterine cancer	0.000702	0.0011	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—uterine cancer	0.000699	0.00109	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Epirubicin—uterine cancer	0.000695	0.00109	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—uterine cancer	0.000692	0.00108	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00069	0.00108	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—uterine cancer	0.000679	0.00106	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—uterine cancer	0.000655	0.00102	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—uterine cancer	0.000653	0.00102	CcSEcCtD
Desvenlafaxine—Insomnia—Epirubicin—uterine cancer	0.000651	0.00102	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—uterine cancer	0.00065	0.00102	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—uterine cancer	0.000647	0.00101	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—uterine cancer	0.000646	0.00101	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000643	0.00101	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—uterine cancer	0.000639	0.001	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—uterine cancer	0.000625	0.000978	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000621	0.000971	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—uterine cancer	0.00062	0.00097	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—uterine cancer	0.000615	0.000962	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—uterine cancer	0.000602	0.000941	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—uterine cancer	0.000598	0.000934	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—uterine cancer	0.000592	0.000925	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—uterine cancer	0.000579	0.000905	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000575	0.000898	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—uterine cancer	0.000574	0.000897	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—uterine cancer	0.000569	0.00089	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Epirubicin—uterine cancer	0.00053	0.000829	CcSEcCtD
Desvenlafaxine—Asthenia—Epirubicin—uterine cancer	0.000516	0.000807	CcSEcCtD
Desvenlafaxine—Diarrhoea—Epirubicin—uterine cancer	0.000492	0.00077	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—uterine cancer	0.00049	0.000767	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—uterine cancer	0.000478	0.000747	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—uterine cancer	0.000476	0.000744	CcSEcCtD
Desvenlafaxine—Vomiting—Epirubicin—uterine cancer	0.000457	0.000715	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—uterine cancer	0.000455	0.000712	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—uterine cancer	0.000454	0.000709	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—uterine cancer	0.000453	0.000708	CcSEcCtD
Desvenlafaxine—Headache—Epirubicin—uterine cancer	0.000451	0.000705	CcSEcCtD
Desvenlafaxine—Dizziness—Doxorubicin—uterine cancer	0.00044	0.000688	CcSEcCtD
Desvenlafaxine—Nausea—Epirubicin—uterine cancer	0.000427	0.000668	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—uterine cancer	0.000423	0.000662	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—uterine cancer	0.00042	0.000656	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—uterine cancer	0.000419	0.000656	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—uterine cancer	0.000417	0.000652	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—uterine cancer	0.000395	0.000618	CcSEcCtD
